Neuroendocrine Tumor Treatment Market Size, Share & Trends Report

Neuroendocrine Tumor Treatment Market Size, Share & Trends Analysis Report By Site (Small Intestine, Pancreas), By End Use (Hospitals, Clinics), By Product (SSA, Targeted Therapy), And Segment Forecasts, 2018 - 2025

Report ID: GVR-2-68038-624-0
Number of Pages: 100
Format: Electronic (PDF)

Historical Range: 2014 - 2016
Industry: Healthcare

Market Segmentation

Neuroendocrine Tumor Treatment Product Outlook (Revenue, USD Million, 2014 - 2025)
- Somatostatin Analogs (SSAs)
- Targeted Therapy
- Others
Neuroendocrine Tumor Treatment Site Outlook (Revenue, USD Million, 2014 - 2025)
- Lungs
- Pancreas
- Colon
- Small intestine
- Others
Neuroendocrine Tumor Treatment End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals
- Clinics
- Others
Neuroendocrine Tumor Treatment Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
  - North America neuroendocrine tumor treatment market by product
    - Somatostatin analogs
    - Targeted therapy
    - Others
  - North America neuroendocrine tumor treatment market my site
    - Lungs
    - Pancreas
    - Colon
    - Small intestine
    - Others
  - North America neuroendocrine tumor treatment market by end-use
    - Hospitals
    - Clinics
    - Others
  - The U.S.
    - U.S. neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - U.S. neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - U.S. neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
  - Canada
    - Canada neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - Canada neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - Canada neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
- Europe
  - Europe neuroendocrine tumor treatment market by product
    - Somatostatin analogs
    - Targeted therapy
    - Others
  - Europe neuroendocrine tumor treatment market my site
    - Lungs
    - Pancreas
    - Colon
    - Small intestine
    - Others
  - Europe neuroendocrine tumor treatment market by end-use
    - Hospitals
    - Clinics
    - Others
  - Germany
    - Germany neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - Germany neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - Germany neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
  - The U.K.
    - U.K. neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - U.K. neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - U.K. neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
- Asia Pacific
  - Asia Pacific neuroendocrine tumor treatment market by product
    - Somatostatin analogs
    - Targeted therapy
    - Others
  - Asia Pacific neuroendocrine tumor treatment market my site
    - Lungs
    - Pancreas
    - Colon
    - Small intestine
    - Others
  - Asia Pacific neuroendocrine tumor treatment market by end-use
    - Hospitals
    - Clinics
    - Others
  - China
    - China neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - China neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - China neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
  - India
    - India neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - India neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - India neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
- Latin America
  - Latin America neuroendocrine tumor treatment market by product
    - Somatostatin analogs
    - Targeted therapy
    - Others
  - Latin America neuroendocrine tumor treatment market my site
    - Lungs
    - Pancreas
    - Colon
    - Small intestine
    - Others
  - Latin America neuroendocrine tumor treatment market by end-use
    - Hospitals
    - Clinics
    - Others
  - Mexico
    - Mexico neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - Mexico neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - Mexico neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
  - Brazil
    - Brazil neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - Brazil neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - Brazil neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others
- Middle East & Africa
  - The Middle East & Africa neuroendocrine tumor treatment market by product
    - Somatostatin analogs
    - Targeted therapy
    - Others
  - The Middle East & Africa neuroendocrine tumor treatment market my site
    - Lungs
    - Pancreas
    - Colon
    - Small intestine
    - Others
  - The Middle East & Africa neuroendocrine tumor treatment market by end-use
    - Hospitals
    - Clinics
    - Others
  - South Africa
    - South Africa neuroendocrine tumor treatment market by product
      - Somatostatin analogs
      - Targeted therapy
      - Others
    - South Africa neuroendocrine tumor treatment market my site
      - Lungs
      - Pancreas
      - Colon
      - Small intestine
      - Others
    - South Africa neuroendocrine tumor treatment market by end-use
      - Hospitals
      - Clinics
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.